联合体育训练保护左心室免受实验性肺动脉高血压的结构和功能损伤
Luciano Bernardes Leite1, Leôncio Lopes Soares2, Alexandre Martins Oliveira Portes3
1Department of Physical Education, Laboratory of Exercise Biology, Federal University of Viçosa, Viçosa, Brazil. luciano.leite@ufv.br.
联合体育训练改善了生存率,并保护了肺动脉高血压 (PAH) 的老鼠的左心室 (LV). 运动减轻了不良改造,氧化应激,并在PAH发展期间保持LV功能.
科学领域:
- 心血管生理学心血管生理学
- 运动科学 运动科学
- 病理学 病理学 病理学
背景情况:
- 肺动脉高血压 (PAH) 会导致右心室的逆转型,损害左心室 (LV) 的功能.
- 联合有氧和抵抗训练对PAH中LV动态的具体影响尚不清楚.
研究的目的:
- 为了确定中等强度的联合体育训练是否有利于LV结构和功能在PAH发育期间在老鼠模型中.
主要方法:
- 患有单克罗他林 (MCT) 诱导的PAH的老鼠接受了为期4周的综合训练计划 (有氧和抵抗运动).
- 心声学评估了LV功能;氧化应激标志物和LV重塑被分析.
主要成果:
- 训练改善了生存率,运动耐力,并防止了喷射分数和分数缩短的减少.
- 体育训练减轻了氧化应激,抑制了不良的LV重塑,保持了肌细胞收缩和细胞内的短暂动态.
结论:
- 中等强度的联合体育训练可以保护大鼠LV免受MCT诱导的PAH损伤.
- 这种训练增强了体力劳动的耐受性,并延长了PAH模型中的存活时间.
更多相关视频
09:40Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice
Published on: May 13, 2019
04:49Author Spotlight: Investigating the Underlying Mechanisms of Right Ventricular Failure in Pulmonary Hypertension
Published on: June 14, 2024
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Exercise and Cardiac Output
Sustained exercise increases the muscles' oxygen demand, which can be...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
